Publication

Cardiac Function After Radiation Therapy for Breast Cancer

van den Bogaard, V. A. B., van Luijk, P., Hummel, Y. M., van der Meer, P., Schuit, E., Boerman, L. M., Maas, S. W. M. C., Nauta, J. F., Steggink, L. C., Gietema, J. A., de Bock, G. H., Berendsen, A. J., Smit, W. G. J. M., Sijtsema, N. M., Kierkels, R. G. J., Langendijk, J. A., Crijns, A. P. G. & Maduro, J. H., 1-Jun-2019, In : International Journal of Radiation Oncology, Biology, Physics. 104, 2, p. 392-400 9 p.

Research output: Contribution to journalArticleAcademicpeer-review

Copy link to clipboard

Documents

  • Cardiac Function After Radiotherapy for Breast Cancer

    Final author's version, 1 MB, PDF document

    Embargo ends: 04/02/2020

    Request copy

  • Cardiac Function After Radiation Therapy for Breast Cancer

    Final publisher's version, 350 KB, PDF document

    Request copy

DOI

Purpose: The main purpose of this study was to test the hypothesis that incidental cardiac irradiation is associated with changes in cardiac function in breast cancer (BC) survivors treated with radiation therapy (RT).

Methods and Materials: We conducted a cross-sectional study consisting of 109 BC survivors treated with RT between 2005 and 2011. The endpoint was cardiac function, assessed by echocardiography. Systolic function was assessed with the left ventricular ejection fraction (LVEF) (n = 107) and the global longitudinal strain (GLS) of the left ventricle (LV) (n = 52). LV diastolic dysfunction (n = 109) was defined by e' at the lateral and septal region, which represents the relaxation velocity of the myocardium. The individual calculated RT dose parameters of the LV and coronary arteries were collected from 3-dimensional computed tomographyebased planning data. Univariable and multivariable analysis using forward selection was performed to identify the best predictors of cardiac function. Robustness of selection was assessed using bootstrapping. The resulting multivariable linear regression model was presented for the endpoints of systolic and diastolic function.

Results: The median time between BC diagnosis and echocardiography was 7 years. No relation between RT dose parameters and LVEF was found. In the multivariable analysis for the endpoint GLS of the LV, the maximum dose to the left main coronary artery was most often selected across bootstrap samples. For decreased diastolic function, the most often selected model across bootstrap samples included age at time of BC diagnosis and hypertension at baseline. Cardiac dose-volume histogram parameters were less frequently selected for this endpoint.

Conclusions: This study shows an association between individual cardiac dose distributions and GLS of the LV after RT for BC. No relation between RT dose parameters and LVEF was found. Diastolic function was most associated with age and hypertension at time of BC diagnosis. Further research is needed to make definitive conclusions. (C) 2019 Elsevier Inc. All rights reserved.

Original languageEnglish
Pages (from-to)392-400
Number of pages9
JournalInternational Journal of Radiation Oncology, Biology, Physics
Volume104
Issue number2
Early online date11-Feb-2019
Publication statusPublished - 1-Jun-2019

    Keywords

  • GLOBAL LONGITUDINAL STRAIN, ISCHEMIC-HEART-DISEASE, EJECTION FRACTION, RADIOTHERAPY, WOMEN, RECOMMENDATIONS, CARDIOTOXICITY, COMPLICATIONS, MORBIDITY, EXPOSURE

View graph of relations

ID: 76011514